Shanxi Zhendong Pharmaceutical(300158.SZ): Application for new drug of Lactobacillus dual live capsules for vaginal use accepted

Shanxi Zhendong Pharmaceutical (300158.SZ) announced that the new drug application (NDA) for the core product "Vaginal Lactobacillus Duo Live Capsules" of Guangdong Longchuang Pharmaceutical Co., Ltd. (referred to as "Longchuang Medical") in which the company holds a stake has been accepted by the China National Medical Products Administration Drug Evaluation Center (CDE). This drug is a compound preparation, with the main components being Lactobacillus bulgaricus and Lactobacillus rhamnosus, used for the restoration of vaginal flora and the treatment of bacterial vaginosis.